SQI Diagnostics (FRA:XSQ) Dividends per Share : €0.00 (TTM As of Mar. 2023)

View and export this data going back to 2010. Start your Free Trial

What is SQI Diagnostics Dividends per Share?

SQI Diagnostics's dividends per share for the three months ended in Mar. 2023 was €0.00. Its dividends per share for the trailing twelve months (TTM) ended in Mar. 2023 was €0.00. Its Dividend Payout Ratio for the three months ended in Mar. 2023 was 0.00. As of today, SQI Diagnostics's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

SQI Diagnostics Dividends per Share Historical Data

The historical data trend for SQI Diagnostics's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SQI Diagnostics Dividends per Share Chart

SQI Diagnostics Annual Data

Trend

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Dividends per Share

Get a 7-Day Free Trial

SQI Diagnostics Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Dividends per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of SQI Diagnostics's Dividends per Share

For the Diagnostics & Research subindustry, SQI Diagnostics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SQI Diagnostics's Dividend Yield % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, SQI Diagnostics's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where SQI Diagnostics's Dividend Yield % falls into.

SQI Diagnostics Dividends per Share Calculation

Dividends paid to per common share.

SQI Diagnostics (FRA:XSQ) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

SQI Diagnostics's Dividend Payout Ratio for the quarter that ended in Mar. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2023 )	/	EPS without NRI (Q: Mar. 2023 )
	=	0	/	0
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

SQI Diagnostics Dividends per Share Related Terms

Thank you for viewing the detailed overview of SQI Diagnostics's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

SQI Diagnostics (FRA:XSQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SQI Diagnostics Inc (FRA:XSQ) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

36 Meteor Drive, Toronto, ON, CAN, M9W 1A4

Website

https://www.sqidiagnostics.com

SQI Diagnostics Inc is the leader in the field of lung health. The company develops and manufactures respiratory health and precision medicine tests that run on SQI's automated systems. The company is developing tests to simplify and improve COVID-19 antibody monitoring, rapid acute lung injury testing, donor organ transplant informatics, and immunological protein and antibody testing. Its geographical segments are the United States, Canada, and Europe. Canada accounts for more than half of its revenues.

SQI Diagnostics (FRA:XSQ) Headlines

No Headlines